A Single or Multiple Visit Protocol for Collection of DNA/RNA/Serum/Plasma/CSF in Amyotrophic Lateral Sclerosis and related disorders

Study Purpose:

The purpose of this study is to collect DNA, RNA, Serum, Plasma and CSF samples from donors with ALS that will be utilized to delineate vulnerability markers for the disease, enhance the understanding of treatment response and side effects and develop new targets for future drug development.

Study Status:

Recruiting

Disease:

Amyotrophic Lateral Sclerosis (ALS) , Familial ALS , Sporadic ALS

Study Type:

Observational

Type of Intervention:

N/A

Intervention Name:

N/A

Placebo:

N/A

Phase:

N/A

Study Chair(s)/Principal Investigator(s):

John Flax, MD (PrecisionMed)

Clinicaltrials.gov ID:

Neals Affiliated?

No

Coordinating Center Contact Information

Study Sponsor:

PrecisionMed

Participant Duration:

At least 1 visit, but allowed to return for follow up visits if patient so chooses. Visits are conducted at treating physician’s clinic as a normal standard of care visit.

Estimated Enrollment:

500

Estimated Study Completion Date:

01 / 01 / 2025

Posting Last Modified Date:

04 / 15 / 2021

Date Study Added to neals.org:

04 / 15 / 2021